Dario Altamirano, DO
Family Medicine · Hialeah, FLNPI 1871571471
Payments from drug & device makers
Across 1,015 payments — averaging $15,319 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$11.5M
- H. Lundbeck A S$1.3M
- Modernatx, Inc.$1.1M
- AbbVie$736K
- Ipsen Innovation$479K
- Mitsubishi Tanabe Pharma Development America, Inc.$212K
- plus $223K from 19 others
Across 4 payments — averaging $1050.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 234 | $11,468,475 |
| H. Lundbeck A S | 70 | $1,297,938 |
| Modernatx, Inc. | 57 | $1,132,477 |
| AbbVie | 62 | $736,278 |
| Ipsen Innovation | 463 | $478,981 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 8 | $211,528 |
| Siemens Medical Solutions USA, Inc. | 5 | $57,620 |
| Eli Lilly | 10 | $41,048 |
| AstraZeneca | 10 | $38,578 |
| Sanofi US Services Inc. | 6 | $33,659 |
| Astrazeneca UK Limited | 2 | $24,836 |
| Genentech, Inc. | 1 | $19,531 |
| Teva Pharmaceuticals USA, Inc. | 2 | $4,128 |
| Amgen | 31 | $1,038 |
| Shionogi Inc | 1 | $897 |
| Lilly USA, LLC | 21 | $424 |
| Johnson & Johnson | 5 | $291 |
| Merck | 3 | $291 |
| Novo Nordisk | 7 | $152 |
| Boehringer Ingelheim | 2 | $145 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $138 |
| Madrigal Pharmaceuticals | 1 | $99 |
| Exact Sciences | 4 | $80 |
| IBSA Pharma Inc. | 1 | $17 |
| BD | 1 | $17 |
How this compares
$15,548,665 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Hialeah
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Craig CurtisKissimmee$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.